UVA (UVA-1) therapy for the treatment of acute GVHD of the skin

[1]  P. C. van de Kerkhof,et al.  Ultraviolet A phototherapy for sclerotic skin diseases: a systematic review. , 2008, Journal of the American Academy of Dermatology.

[2]  A. M. Burns,et al.  Reduced Intensity Conditioning for Allogeneic Hematopoietic Stem-Cell Transplant Determines the Kinetics of Acute Graft-Versus-Host Disease , 2008, Transplantation.

[3]  E. Tschachler,et al.  Non‐melanoma skin cancer and its risk factors in an Austrian population of heart transplant recipients receiving induction therapy , 2008, International journal of dermatology.

[4]  T. Ono,et al.  UVA1 genotoxicity is mediated not by oxidative damage but by cyclobutane pyrimidine dimers in normal mouse skin. , 2008, The Journal of investigative dermatology.

[5]  A. Gratwohl,et al.  The EBMT activity survey 2006 on hematopoietic stem cell transplantation: focus on the use of cord blood products , 2008, Bone Marrow Transplantation.

[6]  Bryon D Johnson,et al.  Graft-versus-leukemia and graft-versus-host reactions after donor lymphocyte infusion are initiated by host-type antigen-presenting cells and regulated by regulatory T cells in early and long-term chimeras. , 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[7]  B. Bonnekoh,et al.  UVA1 radiation (340-400 nm) interferes with the perforin-granule system of CD8hi+ cytotoxic T lymphocytes in vitro. , 2006, Journal of photochemistry and photobiology. B, Biology.

[8]  H. Deeg,et al.  The clinical spectrum of acute graft-versus-host disease. , 2006, Seminars in hematology.

[9]  N. Chao,et al.  Prophylaxis and treatment of acute graft-versus-host disease. , 2006, Seminars in hematology.

[10]  O. Berthier‐Vergnes,et al.  UVA radiation impairs phenotypic and functional maturation of human dermal dendritic cells. , 2005, The Journal of investigative dermatology.

[11]  J. S. San Miguel,et al.  Influence of the intensity of the conditioning regimen on the characteristics of acute and chronic graft‐versus‐host disease after allogeneic transplantation , 2005, British journal of haematology.

[12]  T. Buchler,et al.  Mycophenolate mofetil for the treatment of acute and chronic steroid-refractory graft-versus-host disease , 2005, Annals of Hematology.

[13]  G. Yanik,et al.  Acute graft versus host disease: pathophysiology, risk factors, and prevention strategies. , 2005, Clinical advances in hematology & oncology : H&O.

[14]  D. Niederwieser,et al.  Medium dose long-wavelength ultraviolet A (UVA1) phototherapy for the treatment of acute and chronic graft-versus-host disease of the skin , 2005, Bone Marrow Transplantation.

[15]  P. Reddy.  Pathophysiology of acute graft‐versus‐host disease , 2003, Hematological oncology.

[16]  Linda A. Lee,et al.  Pathogenesis and treatment of graft-versus-host disease after bone marrow transplant. , 2003, Annual review of medicine.

[17]  M. Maris,et al.  Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation. , 2003, Blood.

[18]  Glenn Merlino,et al.  Ultraviolet radiation and cutaneous malignant melanoma , 2003, Oncogene.

[19]  R. Dawe,et al.  Ultraviolet A1 phototherapy , 2003, The British journal of dermatology.

[20]  F. Gruijl.  Photocarcinogenesis: UVA vs. UVB Radiation , 2002 .

[21]  F. D. de Gruijl.  Photocarcinogenesis: UVA vs. UVB Radiation , 2002, Skin Pharmacology and Physiology.

[22]  R. Storb,et al.  Psoralen and ultraviolet A irradiation (PUVA) as therapy for steroid-resistant cutaneous acute graft-versus-host disease. , 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[23]  J. Simon,et al.  UVA1-Phototherapie Pilotstudie zur Dosisfindung bei der bei akut exazerbierten atopischen Dermatitis , 2001, Der Hautarzt.

[24]  A. Nademanee,et al.  Solid cancers after bone marrow transplantation. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  J. Simon,et al.  [UVA1 phototherapy. Pilot study of dose finding in acute exacerbated atopic dermatitis]. , 2001, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.

[26]  J. Simon,et al.  Recent advances in phototherapy. , 2000, European journal of dermatology : EJD.

[27]  H. Greinix,et al.  Extracorporeal photochemotherapy in the treatment of severe steroid-refractory acute graft-versus-host disease: a pilot study. , 2000, Blood.

[28]  B. Berne,et al.  PUVA and cancer risk: the Swedish follow‐up study , 1999, The British journal of dermatology.

[29]  H. Einsele,et al.  Treatment of acute graft-versus-host disease with PUVA (psoralen and ultraviolet irradiation): results of a pilot study , 1999, Bone Marrow Transplantation.

[30]  J. Krutmann.  Ultraviolet A radiation-induced immunomodulation: molecular and photobiological mechanims. , 1998, European journal of dermatology : EJD.

[31]  L. Klotz,et al.  Evidence that Singlet Oxygen-induced Human T Helper Cell Apoptosis Is the Basic Mechanism of Ultraviolet-A Radiation Phototherapy , 1997, The Journal of experimental medicine.

[32]  R. Tyrrell,et al.  Photocarcinogenesis: an overview. , 1981, The Journal of investigative dermatology.

[33]  J. Krutmann,et al.  Lesional expression of interferon-γ in atopic eczema , 1994, The Lancet.

[34]  J. Krutmann,et al.  Lesional expression of interferon-gamma in atopic eczema. , 1994, Lancet.

[35]  G. Plewig,et al.  [Photochemotherapy (PUVA) of acute graft-versus-host disease]. , 1993, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.

[36]  O. Ringdén.  Management of graft‐versus‐host disease , 1993, European journal of haematology.

[37]  K. Sullivan,et al.  Chronic graft-versus-host disease and other late complications of bone marrow transplantation. , 1991, Seminars in hematology.

[38]  M. Pepe,et al.  Marrow transplantation from HLA-matched unrelated donors for treatment of hematologic malignancies. , 1991, Transplantation.

[39]  G. Gahrton,et al.  A randomized trial comparing use of cyclosporin and methotrexate for graft-versus-host disease prophylaxis in bone marrow transplant recipients with haematological malignancies. , 1986, Bone marrow transplantation.

[40]  H. Deeg,et al.  Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. , 1986, The New England journal of medicine.

[41]  R. Storb,et al.  Treatment of graft‐versus‐host disease in human allogeneic marrow graft recipients: A randomized trial comparing antithymocyte globulin and corticosteroids , 1981, American journal of hematology.

[42]  P. Neiman,et al.  CLINICAL MANIFESTATIONS OF GRAFT‐VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL‐A-MATCHED SIBLING DONOR,S , 1974, Transplantation.